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To enter host cells, vaccinia virus, a prototype poxvirus, can induce
transient macropinocytosis followed by endocytic internalization
and penetration through the limiting membrane of pinosomes by
membrane fusion. Although mature virions (MVs) of the Western
reserve (WR) strain do this in HeLa cells by activating transient
plasma membrane blebbing, MVs from the International Health
Department-J strain were found to induce rapid formation (and
lengthening) of ﬁlopodia. When the signaling pathways underly-
ing these responses were compared, differences were observed at
the level of Rho GTPases. Key to the ﬁlopodial formation was the
virus-induced activation of Cdc42, and for the blebbing response
the activation of Rac1. In addition, unlike WR, International Health
Department-J MVs did not rely on genistein-sensitive tyrosine
kinase and PI(3)K activities. Only WR MVs had membrane fusion
activity at low pH. Inhibitor proﬁling showed that MVs from both
strains entered cells by macropinocytosis and that this was in-
duced by virion-exposed phosphatidylserine. Both MVs relied on
the activation of epidermal growth factor receptor, on serine/
threonine kinases, protein kinase C, and p21-activated kinase 1.
The results showed that different strains of the same virus can
elicit dramatically different responses in host cells during entry,
and that different macropinocytic mechanisms are possible in the
same cell line through subtle differences in the activating ligand.
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virus entry
When the endocytic entry of animal viruses into their hostcells was ﬁrst described, it was assumed that incoming
viruses exploit on-going cellular endocytosis processes. More re-
cently, it has become clear that many viruses are not just passive
cargo but trigger their own endocytic uptake via cellular signaling
pathways (1). Much depends on the nature and physiological state
of the host cells and on the interaction of the viruses with their
receptors (2, 3).
Vaccinia virus (VACV) belongs to the viruses that actively
trigger their endocytic internalization. VACV are large, envel-
oped, double-stranded DNA viruses belonging to the Poxviridae,
and they replicate in the cytoplasm. Two infectious forms of the
virus exist: mature virions (MVs), with a single lipid bilayer sur-
rounding a proteinaceous viral core that contains the viral ge-
nome, and extracellular virions that are like MVs but surrounded
by an additional membrane (4). There are several variants of
VACV, including the two strains used in this study, Western re-
serve (WR) and International Health Department-J (IHD-J).
Entry has mainly been investigated using WR MVs. When
bound to the cell surface, the incoming MVs activate a complex
signaling pathway involving the small GTPase Rac1, its effector
kinase p21-activated kinase 1 (Pak1), and other factors (5). A
change in actin dynamics is induced that leads to transient
membrane blebbing followed by macropinocytic internalization
of virus particles. Because the induction of the signal depends on
the presence of exposed phosphatidylserine (PS) in the viral
membrane (5–7), it has been concluded that the WR MVs make
use of apoptotic mimicry as an entry strategy (5). Penetration of
the WR virus core into the cytosol is triggered by low pH in the
macropinosome (8).
Previous studies have suggested that entry of IHD-JMVsmight
be different. Instead of blebs, they seem to induce narrow plasma
membrane protrusions (9). The IHD-J virus is also more de-
pendent on glycosaminoglycan binding and does not require
acidic vacuolar pH (10). To determine whether the two strains of
VACV do, in fact, use different entry strategies, we compared
their interaction with HeLa cells and found that the immediate
cellular responses to the two strains were quite different. Clearly
the same host cells were capable of activating distinct forms
of macropinocytosis.
Results
IHD-J MVs Induce Filopodia. We have previously shown that WR
MV entry in HeLa cells is preceded by the activation of a com-
plex signaling pathway that induces major alterations in actin
dynamics. This process leads to blebbing of the plasma mem-
brane followed by macropinocytosis that allows internalization of
the incoming virus (5).
Because it has been reported that instead of blebs, IHD-J MVs
induce membrane protrusions (9), we tested the two strains side
by side in HeLa cells. A clear difference in host-cell response was
detected almost immediately after addition of viruses to cells.
Although WR MVs caused the transient formation of numerous
actin-containing membrane blebs over the surface of the cells
(Fig. 1A, WR), exposure to IHD-J MVs resulted in a dramatic
increase in the number and length of ﬁlopodia (Fig. 1A, IHD-J).
Their number and surface density increased 4- to 5-fold, and the
average length 3- to 4-fold compared with those in uninfected or
WR MV-treated cells (Fig. 1 B–D). Like the formation of blebs
with WR, the extension of the ﬁlopodia with IHD-J occurred
during the ﬁrst 30 min of exposure to the virus. Unlike the blebs
induced by WR, which were transient, the ﬁlopodia remained
a permanent feature of the infected cells for many hours (Movie
S1,Movie S2, Movie S3, and Fig. S2). The surface area of the cells
did not decrease compared with uninfected cells, indicating that
the ﬁlopodia were not a consequence of cell retraction (Fig. 1E).
Thus, the cellular response to the two VACV strains was, indeed,
dramatically different.
Role of Rho GTPases.WR MV-induced blebbing, endocytosis, and
infection depend on actin, myosin II, and the Rho GTPase Rac1
(5). To test whether this also applied to IHD-J MVs, inhibitors of
actin polymerization and depolymerization (cytochalasin D and
jasplakinolide) and myosin II (blebbistatin) were ﬁrst tested.
IHD-J and WR MV infection were both efﬁciently inhibited by
these compounds indicating that actin dynamics played a central
role in the infection of both viruses (Fig. 2 A and B).
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When all Rho GTPases—including Rho A, Rac1, and Cdc42—
that regulate actin dynamics were inhibited using Clostridium
difﬁcile toxin B, a decrease of 30 to 40% in infection by IHD-J and
WR was observed (Fig. 2C). However, all three GTPases were
found to be rapidly and robustly activated when either virus strain
was added (Fig. 2 D and E). Activation of RhoA was transient,
whereas activation of Rac1 and Cdc42 lasted for more than 60min
with bothWRand IHD-J (Fig. 2D andE). Cdc42 showed themost
robust response to IHD-J, with maximal activation reached within
15 min (Fig. 2D); Rac1 was most responsive to WR (Fig. 2E).
Thus, it was apparent that by binding to cells both viruses were
capable of activating all three GTPases but with some differences.
When the impact of individual RhoGTPases was determined by
expressing the constitutive-active (C/A) and dominant-negative
(D/N) forms, more distinct differences emerged. MVs of the IHD-
J strain were dependent on Cdc42 for infection. The expression of
A
B C D E
Fig. 1. Virus-induced cytoskeletal rearrangement is strain de-
pendent. (A) HeLa cells were left uninfected, or were infected
with IHD-J or WR MVs [multiplicity of infection (MOI) = 10];
30 min after infection, cells were ﬁxed, stained for actin, and
imaged. (B–E) Cells treated as in A were subjected to quanti-
tative measurements, including number of ﬁlopodia per cell (B),
ﬁlopodia per micrometer (C), ﬁlopodia length (D), and 2D cell
size (E). Fifty cells per experiment were analyzed in triplicate
and the average displayed with SE.
Fig. 2. Actin dynamics, myosin II, and Cdc42 are required for IHD-J infection. (A–C) Cells were pretreatedwith various concentrations of cytochalasin D (CytoD),
jasplakinolide (Jasp), blebbistatin A (Bleb), or Toxin B, followed by infection with IHD-J- or WR-EGFP-MVs. Infection was scored by ﬂow cytometry. (D and E)
A time course was performed in HeLa cells with IHD-J or WRMVs (MOI = 10). GTPase activities were measured using GTPase-speciﬁc G-Lisa assays. (F) HeLa cells
were transfected with GFP-tagged WT, D/N, or C/A Rac1, RhoA, or Cdc42. Cells were infected with IHD-J- or WR-mRFP-MVs and analyzed for transfection and
infection. (G) HeLa cells were transfected with siRNA targeting RhoA, Cdc42, or Rac1. Cells were infected with IHD-J- or WR-EGFP-MVs and infection quantiﬁed
at 6 h after infection (Left). The protein knockdown was determined by immunoblot analysis (Right). Tubulin served as a loading control. Experiments were
carried out in triplicate and the average displayed with SE.









the D/N decreased IHD-J infection by 75%, and the C/A form
increased it by 20% (Fig. 2F). Conversely, expression of Rac 1
mutants had no impact on IHD-J infection (Fig. 2F). Both D/N
Rac1 and Cdc42 reducedWR infection by 30%; the C/ARac1 and
Cdc42 mutants had little effect (Fig. 2F). Expression of C/ARhoA
reduced infection of both viruses by 50%, and the D/N construct
had little effect on either virus (Fig. 2F).
To validate the different requirements for the GTPases during
infection, we used small interfering RNAs (siRNAs) directed
against RhoA, Cdc42, and Rac1. These siRNAs gave 64, 67, and
59% knockdown of these proteins, respectively (Fig. 2G, Right).
Knockdown of Cdc42 reduced IHD-J MV infection by 75%, but
depletion of Rac1 had no effect (Fig. 2G, Left). For WR MVs,
depletion of Rac1 and Cdc42 inhibited infection by 70 and 30%,
respectively (Fig. 2G, Left). Knockdown of RhoA had no impact
on either IHD-J or WR infection.
These results indicated that Cdc42 was the primary Rho
GTPase required for IHD-J MV infection, consistent with its
well-documented role in regulating the formation of ﬁlopodia
(11). We have previously shown that Rac1 is not only required
for productive entry of WR MVs, but also for the virus-induced
formation of blebs and macropinocytic internalization of virus
particles (5). Although Rac1 is the key GTPase promoting in-
fection by WRMVs, the impact of D/N Cdc42 and Cdc42 siRNA
suggests that Cdc42 may also be important. That expression of
the constitutively active RhoA inhibited infection conﬁrmed
previous data on WR virus (12). This inhibitory effect provided
a possible explanation for the effect of Toxin B, which only gave
partial inhibition of infection; the toxin may have simultaneously
increased infection by inactivating RhoA, and decreased it by
inhibiting Cdc42 and Rac1.
Epidermal Growth Factor Receptor-TK Activity Is Required for IHD-J
and WR MV Entry. The epidermal growth factor receptor (EGFR)
is often associated with activation of Rho family GTPases and
actin rearrangement. In addition, its activation is known to
trigger macropinocytosis, the endocytic mechanism used by WR
MVs for entry into HeLa cells (5, 13).
We found that EGFR was rapidly (within 1–5 min) activated by
both IHD-J andWRMVs (Fig. 3A) to a 4.5- to 5.5-fold higher level
than in uninfected cells, and sustained for at least 60 min. Cyclo-
heximide was used in these experiments to prevent the expression
of early viral genes that could inﬂuence receptor activity (14).
To determine whether EGFR activation was essential for
VACV infection in HeLa cells, we tested two inhibitors of this
receptor tyrosine kinase, Iressa and 324674 (Calbiochem). Both
efﬁciently inhibited IHD-J and WR MV infection in a dose-de-
pendent fashion (Fig. 3 B and C). To assess whether the inhib-
itors caused a block in virus entry or later steps in the infection
cycle, an acid-mediated bypass experiment was performed using
WR MVs (5). Being acid-activated, penetration and infection of
WR MVs can be triggered at the plasma membrane, thus
allowing the virus to bypass the need for blebbing and endocy-
tosis (5). The experiment showed that brief acidiﬁcation of cells
with bound virus allows infection of cells in the presence of both
inhibitors (Fig. 3 B and C, pH 5.0). This result indicated that the
EGFR activation is required for VACV entry and not for sub-
sequent cytosolic steps in the replication cycle.
To validate the speciﬁcity of the two EGFR inhibitors, we made
use of CHO cells. Although these cells lack the EGFR, they
support VACV entry, early gene expression, andDNA replication
(15). Given that entry must follow a mechanism that does not rely
on the EGFR, we reasoned that infection should be insensitive to
the two inhibitors if these are speciﬁc to the EGFR. CHO cells
treated with Iressa or 324674 were, indeed, fully infected by IHD-
J and WR MVs (Fig. 3D). The inhibition seen in HeLa cells was
therefore likely to be EGFR-speciﬁc. We did not pursue the al-
ternative mechanism of entry in CHO cells further, except for
observing that the pathway must really be quite different because,
unlike HeLa cells, infection of CHO cells was not affected by
EIPA, IPA-3, or wortmannin, that inhibit Na+/H+ exchangers,
Pak1, and PI(3) kinases, respectively (Fig. S1).
IHD-J MVs Trigger a Signaling Pathway Similar to WR MVs. Our
studies have shown that the signaling cascade that activates bleb-
bing and subsequent macropinocytosis of WR MVs involves ser-
ine/threonine-, tyrosine-, and phosphatidylinositide kinases, as well
as Na+/H+ exchangers (5). To determine whether these cellular
factors were exploited by IHD-J MVs, we compared the effects of
a panel of inhibitors on IHD-J and WR MV infection and entry.
Infection of both strains was inhibited by staurosporine (general
kinase inhibitor), rottlerin [inhibitor of protein kinaseC (PKC) and
other kinases], IPA-3 [PAK1 inhibitor (16)], and EIPA [Na+/H+
exchange, GTPase activation, andmacropinocytosis inhibitor (17)]
(Fig. 4A–C).Both strainswere also insensitive toGö6979 (calcium-
dependent PKC inhibitor) (Fig. 4A). That infection was insensitive
to chlorpromazine (clathrin coat assembly inhibitor), and dynasore
[dynamin inhibitor (18)] indicated that internalization did not re-
quire clathrin-mediated endocytosis (Fig. 4D). Vesicular stomatitis
virus (VSV), which enters via clathrin-coated pits (19), was blocked
by both of these inhibitors.
When the effect of the inhibitors that did block IHD-J in-
fection was analyzed more closely, it was found that none of
them blocked IHD-J binding to the cells surface (Fig. 4E, white
bars). Rather, a moderate increase in binding was observed.
Using an immunoﬂuorescence-based internalization assay, we
found that the inhibitors all had a dramatic effect (>75% re-
duction) on virus internalization (Fig. 4E, gray bars).
A
B C D
Fig. 3. EGFR-TK activity is required for MV infection of HeLa but not CHO
cells. (A) Serum-starved HeLa cells were infectedwith IHD-J orWRMVs (MOI =
10) in the presence of cycloheximide (1 mM). Cells were harvested at the in-
dicated times and lysates analyzed for activated and total EGFR (Left), the fold
activation over uninfected cells was determined (Right). (B and C) HeLa cells
pretreated with Iressa or 324674 were infected with IHD-J- or WR-EGFP-MVs.
Four hours after infection, cells were analyzed by ﬂow cytometry. An acid-
mediated bypass (pH 5.0) was performed with WR. (D) CHO cells were pre-
treated with Iressa or 324674, infected with IHD-J- or WR-EGFP-MVs, and an-
alyzed by ﬂow cytometry. Experiments were carried out in triplicate and the
average displayed with SE.
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Judging by these results, we concluded that the signaling path-
ways triggered were similar. However, two additional inhibitors
showed that they were not identical. UnlikeWRMVs, infection by
IHD-J MVs was not inhibited by genistein (tyrosine kinase in-
hibitor), nor by wortmannin [PI(3)-kinase inhibitor] (Fig. 4A).
These differences implied that the pathway downstream of the
EGFR diverged between the two strains of virus. This ﬁnding may
explain the differential effects on the Rho GTPases, and hence the
different outcome in cellular response.
Macropinocytosis and Apoptotic Mimicry. The role of the EGFR,
the nature of the signaling pathway, the involvement of Pak1 and
Na+/H+ exchangers, and the actin-dependence all argued for
a macropinocytosis-driven endocytic process for IHD-J. In fur-
ther support of this, we could show by quantitative analysis of
dextran-488 uptake that addition of IHD-J MVs to cells induced
a 6-fold elevation in ﬂuid phase internalization within 30 min
(Fig. 4F). Like WR MV infection, IHD-J MV infection was
inhibited by Annexin 5, a PS-binding protein (Fig. 4G). This
ﬁnding indicated that IHD-J also has PS exposed in the viral
envelope, and that this PS is critical for infection. Taken to-
gether, these results made evident that IHD-J entered and
infected cells by inducing macropinocytic endocytosis via the
exposed PS in the viral envelope.
IHD-J MV Fusion Activity Is Acid-Independent. It has been reported
that the infection by WR MVs is acid-activated, whereas in-
fection by IHD-J MVs is not (10). To conﬁrm and extend this
ﬁnding, we ﬁrst tested the ability of IHD-J and WR MVs to
mediate the formation of syncytia when exposed to low pH.
Formation of syncytia (fusion-from-without) is often used to
demonstrate membrane fusion activity of enveloped viruses.
When cell cultures were exposed to IHD-J MVs, no syncytia
were formed, irrespective of pH treatment (Fig. 5A, pH 7.4 vs.
pH 5.0). In contrast, cells exposed to WR MVs and pH 5.0,
showed extensive cell-cell fusion. The extent of syncytia forma-
tion in the samples was quantiﬁed by determining the fusion
index, f (20). The f-values conﬁrmed that contrary to WR MVs,
which were highly fusogenic at pH 5.0 (f = 0.66), the IHD-J MVs
did not fuse cells at either pH (f = 0.04) (Fig. 5B).
To test whether IHD-J MV entry was dependent on endosomal
acidiﬁcation, baﬁlomycinA1(Baf), a vacuolarATPase inhibitor, and
monensin A (Mon), a carboxylic ionophore, were used to raise the
endosomal pH. IHD-J MVs showed little sensitivity to either in-
hibitor (Fig. 5C, white bars).With 40 to 50% reduction in infectivity,
WR MV entry into HeLa cells proved to be partially sensitive, as
previously reported (Fig. 5C, light gray bars) (21). VSV, known to
penetrate from early endosomes by acid-activatedmembrane fusion
(19, 22), was inhibited by more than 90% (Fig. 5C, dark gray bars).
We conclude that the membrane fusion activities of IHD-J and
WR MVs are different in respect to acid-dependence. Whereas
IHD-J can infect cells without acidiﬁcation, WR MVs possesses
a latent acid-activatedmembrane fusion activity. About half of the
infectious particles showed such acid-dependence during HeLa
cell infection.
Discussion
The overall effect of WR and IHD-J MVs on HeLa cells was dra-
matically different. Instead of the transient formation of multiple
blebs over the surface of cells seen with WR MVs, IHD-J MVs
A B C D
E F G
Fig. 4. IHD-JMVs enter cells by PS-mediatedmacropinocytosis. (A–C) Cellswere pretreatedwith staurosporine (Stau), genistein (Geni), wortmannin (Wort), rottlerin
(Rott), Gö6979, IPA-3 and PIR 3.5, or EIPA and infected with IHD-J- orWR-EGFP-MVs. Four hours after infection, cells were analyzed by ﬂow cytometry. (D) Inhibitor
assays were performed as in A. VSV served as a control (22). (E) Binding: IHD-J-EGFP-COREMVs (MOI = 5) were bound to HeLa cells in the presence of the maximum
inhibitor concentrations. Binding was assessed by ﬂow cytometry. Internalization: HeLa cells pretreated with inhibitors were infected with IHD-J-EGFP-CORE MVs.
Thirtyminutespostinfeciton,external virionswere stainedwithMab7D11and internalizedvirionsquantiﬁed. (F) Uptakeof70-kDadextranwasassayed inuntreated,
IHD-J, orWRMV-infected cells at the indicated times. Cells treatedwith EGF served as a positive control. (G) Untreatedor ANX5-treated IHD-J- orWR-EGPF-MVswere
used to infect cells. Four hours after infection, cells were analyzed for infection. Experiments were performed in triplicate and the average displayed with SE.









triggered permanent induction and lengthening of ﬁlopodia. At the
molecular level, differences were found in the dependence of Rho
GTPase, the activation of PI(3)-kinases and genistein-sensitive ty-
rosine kinases, and the requirement for endosome acidiﬁcation.
That the sameHeLa cells could respond toclosely related stimuli by
activating different macropinocytic programs was evident.
Despite the many differences, it was also apparent that the
mechanismsof entry of the twoVACVstrains had similarities.Both
viruses activated the EGFR and triggered a complex signaling
cascade that caused a global alteration of actin dynamics. A change
in cell behavior was thus induced, including macropinocytic in-
ternalization of virus particles. Furthermore, as far as we could
determine, both viruses employedanoverall entry strategybasedon
“apoptotic mimicry,” as previously described for theWRMVs (5).
The cellular responseswere in each case rapid,with activationof all
threeRhoGTPases occurring within 5min. A key trigger was in both
cases the exposed PS in the viral envelope, the only lipid in the virus
membrane speciﬁcally required for infectivity (5–7). Although the
cellular PS-sensors involved remain unidentiﬁed, PS-receptors have
been described mainly in macrophages as components of the ma-
chinery needed for endocytosis of apoptotic bodies. Some of these
surfaceproteinsbindPSdirectly, othersusebridgingmolecules to link
PS-recognition with receptor activation (23–27). Some contain EGF-
like domains that could serve to transactivate the EGFR (24, 27, 28).
Our results clearly deﬁned activation of EGFR as a necessary
step in infection of HeLa cells. Blocking this receptor with anti-
bodies and other agents has previously been shown to inhibit
VACV infection in L cells (29, 30). However, its role as a VACV
receptor has been largely dismissed because the virus infects cells,
such as CHO cells, devoid of EGFR (31). Consistent with this, we
found that two EGFR inhibitors that blocked infection in HeLa
cells had no effect on VACV infection in CHO cells. Because we
also failed to observe inhibition by Na+/H+ exchanger- or PAK-1
inhibitors—and in the case ofWRMVs, of PI(3)K inhibitors—we
concluded that infection of CHO cells does not involve macro-
pinocytosis. Apparently, VACV belongs to a growing group of
viruses that seem to make use of different, alternative strategies
and pathways to enter cells. Herpes simplex virus is a well-studied
example of this; it enters some cell types by endocytosis and others
by direct fusion at the plasma membrane (32).
When the signaling pathways downstream of the EGFR were
analyzed, it was found that the two strains shared the need for actin,
myosin II, RhoGTPases, PAK1, andNa+/H+-exchangers. Although
all three of the Rho GTPases were activated within minutes by both
viruses, Cdc42 responded most robustly to IHD-J, and Rac1 toWR.
Expression of a D/N construct and siRNA silencing showed that
Cdc42 was, indeed, critical for infection by IHD-J, consistent with its
role as the key regulator in ﬁlopodia formation (33). It has been
previously reported that Rac1 is required for IHD-J entry (9). Al-
though we conﬁrmed that Rac1 was activated by IHD-J, we saw no
effect of D/N and C/A constructs or siRNA silencing on IHD-J in-
fection. In contrast, we have shown previously that Rac1 allows WR
MVs to trigger plasma membrane blebbing (5), and have now dem-
onstrated that bothRac1 andCdc42 contribute toWRMVinfection.
Activation ofRhoAwas transient for both strains. Judging by the
effect of a C/A mutant, this activation was actually inhibitory to
infection, as previously reported (9). However, under unperturbed
conditions, the inhibitory effect was most likely overwhelmed by
the activating effects of the other two GTPases. In many systems
opposing effects of RhoA, and Rac1 (or Cdc42) have been ob-
served (34, 35).
Several kinase inhibitors blocked entry of both strains, including
staurosporin, IPA-3, and rottlerin. However, IHD-J infection dif-
fered fromWR in being insensitive to moderate concentrations of
tyrosine- and PI(3)- kinase inhibitors. Although most forms of
macropinocytosis are known to depend on PI(3)-kinases (36),
exceptions have been reported (37).
Although differences in the virus particles must be the ultimate
explanation for the observed variations in cellular response, we are
not aware of any in structure or composition. However, there are
functional differences: IHD-J is more dependent on GAGs for
infection than WR and less dependent on acidiﬁcation (10). In
respect to acidiﬁcation, we found that half of the WR MVs were
inhibited by agents that elevate vacuolar pH. By assaying for virus-
induced cell-cell fusion, we could correlate the acid requirement
with viral membrane fusion activity. VACV has a membrane
protein complex composed of at least 12 viral proteins involved in
viral fusion and its regulation (38, 39). It remains to be determined
if variations in these complexes account for the differences seen in
IHD-J and WR MV acid dependence and cell-cell fusion activity.
When considering what could cause the differential outcome
with the two viruses, the experimental clues we have point toward
the differences in GTPase and kinase dependency. On this basis,
we speculate that the surface-bound virus particles differ in how
they interact with the EGFR. This interaction may lead to dif-
ferences in receptor clustering and spatial distribution, thereby
stimulating the activation of different subsets of kinases. This
result, in turn, could cause a downstream divergence in GTPase
activation. Other scenarios are also possible, such as a difference
in receptors activated in addition to EGFR, and a divergence in
the fate of endocytic vacuoles after internalization. Tyrosine- and
PI(3)-kinase activities are also required downstream of the
GTPases in the signaling pathway triggered by WR VACV MVs,
suggesting that they may participate in the regulation of macro-
pinosomes (5).
Fig. 5. IHD-J MV fusion activity is acid-independent. (A) IHD-J- or WR-MVs
(MOI = 10)were bound toHeLa cells at 25 °C. Cellswerewashedand treatedwith
pH 7.4 or pH 5.0 media for 5 min, then incubated for 2 h at 37 °C at neutral pH.
Cells were imaged by confocalmicroscopy for both nuclei and actin. Experiments
were performed in triplicate and representative images displayed. (Scale bars,
20μm). (B) The fusion index (f) for eachsample inAwasquantiﬁedasdescribed in
Materials and Methods. (C) HeLa cells were pretreated with various concen-
trationsof BaforMonand infectedwith IHD-J-EGFP-MVs (MOI=1). Infectionwas
analyzed by ﬂow cytometry. WR MVs and VSV were assayed in parallel. Experi-
ments were performed in triplicate and the average displayed with SE.
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In summary, we observed that closely related virus particles
were capable of eliciting different macropinocytic programs in
the same cells. It is known that macropinocytosis can differ be-
tween cells (36), but here two distinct responses were observed in
the same cells. The plasticity of VACV and its interaction with
host cells revealed by our observations demonstrated that the
virus is capable of exploiting a repertoire of alternative host-cell
responses. This reaction may provide an evolutionary advantage
that VACV shares with other viruses known to use multiple entry
mechanisms, including herpes viruses and inﬂuenza viruses (40).
Materials and Methods
Cells, Viruses, Plasmids, and Reagents. HeLa and CHO cells were maintained in
DMEM (Gibco BRL) supplemented with 10% FCS, glutamax, and nonessential
amino acids. Wild-type (IHD-J and WR), XFP-expressing (IHD-J/WR-EGFP/mRFP-
MV), and EGFP-tagged A5 (IHD-J/WR-EGFP-CORE) VACV were generated, puri-
ﬁed, and titered as previously described (5). Plasmids encoding pEGFP Rac1,
RhoA, andCdc42 variantswereobtained from IanMacara (University of Virginia
School of Medicine, Charlottesville, VA). Baﬁlomycin A1, monensin A, Clostrid-
ium difﬁcile toxin B, cytochalasin D, genistein, staurosporine, rottlerin, wort-
mannin, EIPA, dynasore, chlorpromazine, and cycloheximide were obtained
from Sigma-Aldrich, jasplakinolide from Invitrogen, Gö 6979 and 324674 from
Calbiochem, Iressa from LC Laboratories, Rhodamine phalloidin fromMolecular
Probes, andDraq5 fromBiostatus Limited. IPA-3 andPIR 3.5wereobtained from
Jeffery Peterson (Fox Chase Cancer Center, Philadelphia, PA).
Syncytia Formation.MVs (MOI=10)werebound to cells at25 °C.Afterwashing,
media (pH 7.4 or pH 5.0; 20mMMes) was added for 5 min at 37 °C. Cells were
washed and incubated at 37 °C for 2 h. Cells were stained for nuclei and actin.
The number of cells and nuclei per imagewere quantiﬁed. A fusion index was
calculated using the equation f = [1 − (C/N)], as previously described (20).
GTPase Activation.MVs were bound to serum-starved cells (MOI = 10) at 25 °C.
Cells were washed, shifted to 37 °C, and harvested at the indicated times.
G-LISA activation kits (Cytoskeleton, Inc.) were used to measure Cdc42, Rac1,
and RhoA activation.
GTPase siRNA. Cells were transfected with Qiagen control (1027280), RhoA
(SI02654211), Cdc42 (SI02757328), or Rac1 (SI02655051) siRNA at a concen-
tration of 20 nM. Forty-eight hours later, cells were infected with EGFP-MVs
(MOI = 0.2). Cells were ﬁxed 6 h after infection and analyzed. Antibodies
directed against RhoA, Cdc42, and Rac1 (ARH03-A, ACD03-A, ARC03-A;
cytoskelton) were used to determine knockdown efﬁciency.
EGFR Activation.MVs(MOI=10)wereboundtoserum-starvedcellsat25°C.Cells
were washed and fed with media containing cycloheximide (1 mM), shifted to
37 °C, and harvested at the indicated times. Cell lysates were analyzed for total
(anti-EGFR; Millipore) and phospho-EGFR(Tyr-1173) (clone 9H2; Upstate).
Flow Cytometry. Inhibitor experiments. Cells were pretreated with the indicated
inhibitors before infection with EGFP-MVs (MOI = 1). Flow cytometry was
performed as previously described (5).
D/N or C/A mutants. Cells were transfected with the indicated plasmids and 18 h
later infected with mRFP-MVs (MOI = 1). Cells were analyzed by ﬂow
cytometry for infection and transfection.
MV Binding and Internalization. Binding. Cells were treated with inhibitors
before binding of EGFP-CORE virus (MOI = 5) at 25 °C. Cells were washed and
analyzed by ﬂow cytometry.
Internalization. EGFP-CORE virions (MOI = 40) were bound to cells at 25 °C,
washed, and shifted to 37 °C for 30 min. External virions were distinguished
using an antibody against L1R (1:10,000; a gift of A. L. Schmaljohn, University
of Maryland School of Medicine, Baltimore, MD) followed by Alexa594 sec-
ondary antibody. Samples were analyzed using confocal microscopy.
Fluid Phase Uptake. Cells were boundwith EGF (100 ng/ml), IHD-J-, orWR-MVs
(MOI=10),washed, and incubatedwith0.5mg/mL70kDaFITC-dextranat37 °C
for the indicated times. Surface-bound dextran was removed with (0.1 M
sodium acetate, 0.05 M NaCl, pH 5.5), and cells analyzed by ﬂow cytometry.
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